D
Inhibikase Therapeutics, Inc. IKT
$2.37 $0.010.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -16.50% -6.67% -11.29% 9.08% 20.47%
Total Depreciation and Amortization 0.00% 0.00% 0.00% 0.00% -95.85%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 382.08% -42.51% -60.88% -7.21% 17.87%
Change in Net Operating Assets 662.42% -118.27% 21.98% 76.05% -63.76%
Cash from Operations 3.43% -30.71% -12.33% 16.14% 10.08%
Capital Expenditure -- -- -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -0.67% 176.79% -56.54% -112.40% 565.39%
Cash from Investing -0.67% 176.79% -56.54% -112.40% 569.09%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -94.34% 708.25% 79,420.00% 400.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 200.00% 77.92% -- --
Cash from Financing -94.39% 784.01% 365.75% -138,200.00% 100.28%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -396.41% 110.76% -19.59% -143.96% 731.55%
Weiss Ratings